X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs MYLAN (US) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   MYLAN
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-17
MYLAN
Dec-14
PIRAMAL ENTERPRISES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs2,0954,043-   
Low Rs1,0252,849-   
Sales per share (Unadj.) Rs492.81,384.2-  
Earnings per share (Unadj.) Rs72.6166.7-  
Cash flow per share (Unadj.) Rs94.7268.4-  
Dividends per share (Unadj.) Rs21.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs862.5688.1-  
Shares outstanding (eoy) m172.56378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x3.22.5 127.1%   
Avg P/E ratio x21.520.7 104.0%  
P/CF ratio (eoy) x16.512.8 128.3%  
Price / Book Value ratio x1.85.0 36.1%  
Dividend payout %28.90-   
Avg Mkt Cap Rs m269,1941,303,966 20.6%   
No. of employees `0004.025.0 16.1%   
Total wages/salary Rs m17,9390-   
Avg. sales/employee Rs Th21,190.320,949.0 101.2%   
Avg. wages/employee Rs Th4,470.10-   
Avg. net profit/employee Rs Th3,120.02,523.6 123.6%   
INCOME DATA
Net Sales Rs m85,037523,725 16.2%  
Other income Rs m2,338-3,053 -76.6%   
Total revenues Rs m87,374520,672 16.8%   
Gross profit Rs m34,991130,253 26.9%  
Depreciation Rs m3,81738,465 9.9%   
Interest Rs m20,31022,591 89.9%   
Profit before tax Rs m13,20266,144 20.0%   
Minority Interest Rs m1,699-271 -626.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1000-   
Tax Rs m2,2812,781 82.0%   
Profit after tax Rs m12,52063,091 19.8%  
Gross profit margin %41.124.9 165.5%  
Effective tax rate %17.34.2 410.9%   
Net profit margin %14.712.0 122.2%  
BALANCE SHEET DATA
Current assets Rs m87,590460,423 19.0%   
Current liabilities Rs m185,578359,959 51.6%   
Net working cap to sales %-115.219.2 -600.7%  
Current ratio x0.51.3 36.9%  
Inventory Days Days3178 39.8%  
Debtors Days Days48107 44.3%  
Net fixed assets Rs m108,523121,162 89.6%   
Share capital Rs m34518,520 1.9%   
"Free" reserves Rs m148,4810-   
Net worth Rs m148,826260,343 57.2%   
Long term debt Rs m144,957388,927 37.3%   
Total assets Rs m482,3941,048,637 46.0%  
Interest coverage x1.73.9 42.0%   
Debt to equity ratio x1.01.5 65.2%  
Sales to assets ratio x0.20.5 35.3%   
Return on assets %6.88.2 83.3%  
Return on equity %8.424.2 34.7%  
Return on capital %12.013.6 87.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m9,8510-   
CASH FLOW
From Operations Rs m-100,39368,844 -145.8%  
From Investments Rs m-24,202-54,292 44.6%  
From Financial Activity Rs m135,705-18,140 -748.1%  
Net Cashflow Rs m11,110-3,589 -309.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 67.84 Rs / USD

Compare PIRAMAL ENTERPRISES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: NOVARTIS  GLENMARK PHARMA  FRESENIUS KABI ONCO.  JUBILANT LIFE SCIENCES  PLETHICO PHARMA  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY18); Net Profit Up 1230.7% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 39 bn (up 1230.7% YoY). Sales on the other hand came in at Rs 30 bn (up 21.5% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Jun 22, 2018 03:37 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - ABBOTT INDIA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS